News

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Calling AbbVie Inc. (NYSE:ABBV) one of his “absolute favorites” during the recent episode of Mad Money, Cramer said: “Or how ...
Citigroup has reiterated its neutral stance on AbbVie, nudging its price target down from $210 to $205, despite the company’s ...
Tune into earnings calls Now streaming directly on quote pages.